Yeaman, Michael R.
Article History
First Online: 16 May 2014
Competing interests
: M.R.Y. is a founder and shareholder of NovaDigm Therapeutics, Inc., and founder and shareholder of Metacin, Inc., neither of which provided support for the current manuscript. He is a cited inventor of anti-infective peptides and mimetics thereof, as well as of cross-kingdom vaccines.